Multimodal Study of the Human Brain Epilepsy Tissue

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy. The aim of the study will be to identify new pathophysiological pathways. For this purpose, the investigators will investigate with a multimodal approach blood and brain samples from patients undergoing a surgery for focal drug-resistant epilepsy. The adult patients will be enrolled either during the pre-surgical evaluation or right before the surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 yo or above

• patients with a focal drug-resistant epilepsy

• patients hospitalized for a pre-surgical evaluation or for an epilepsy surgery

• consent obtained from the patient, or legally authorized representative

• affiliated to a social security system

Locations
Other Locations
France
Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital
RECRUITING
Paris
Contact Information
Primary
Vincent M. Navarro, MD, PHD
Vincent.navarro@aphp.fr
01 42 16 19 40
Backup
Aurélie Ms Hanin, PharmD, PhD
Aurelie.hanin@icm-institute.org
01 57 27 40 56
Time Frame
Start Date: 2024-02-29
Estimated Completion Date: 2037-02-28
Participants
Target number of participants: 150
Treatments
Experimental: epileptic patients
All patients will be enrolled in the same arm. Patients can be enrolled during the pre-surgical evaluation (group 1) or in the days preceding the surgery (group 2).
Related Therapeutic Areas
Sponsors
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France, ICM Co. Ltd.
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov